Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Baricitinib in Patients With Relapsing or naïve Dermatomyositis (BIRD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04972760
Recruitment Status : Not yet recruiting
First Posted : July 22, 2021
Last Update Posted : April 8, 2022
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2025